Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

1.

Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE.

JAMA. 1998 Mar 4;279(9):657-62.

PMID:
9496982
2.

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.

PMID:
10847254
3.
4.

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE.

Ann Intern Med. 2004 Nov 16;141(10):745-52.

PMID:
15545674
5.
6.

A review of warfarin dosing with concurrent acetaminophen therapy.

Pinson GM, Beall JW, Kyle JA.

J Pharm Pract. 2013 Oct;26(5):518-21. doi: 10.1177/0897190013488802. Epub 2013 Jun 3. Review.

PMID:
23736105
7.
8.

The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.

Parra D, Beckey NP, Stevens GR.

Pharmacotherapy. 2007 May;27(5):675-83.

PMID:
17461702
9.

The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.

Suwanawiboon B, Kongtim P, Chinthammitr Y, Ruchutrakool T, Wanachiwanawin W.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S225-31.

PMID:
21721451
10.

Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.

Schultz KT, Bungard TJ.

Pharmacotherapy. 2011 Aug;31(8):793-805. doi: 10.1592/phco.31.8.793.

PMID:
21923606
11.

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE.

JAMA. 2002 Apr 3;287(13):1690-8.

PMID:
11926893
12.

Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.

Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.

Ann Pharmacother. 2011 Jul;45(7-8):881-7. doi: 10.1345/aph.1P670. Epub 2011 Jul 12.

PMID:
21750309
13.

Falsely elevated international normalized ratio values in patients undergoing anticoagulation therapy: a descriptive evaluation.

Delate T, Witt DM, Jones JR, Bhardwaja B, Senser M.

Chest. 2007 Mar;131(3):816-822. doi: 10.1378/chest.06-2200.

PMID:
17356098
14.

Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics.

Cryder B, Felczak M, Janociak J, Dela Pena L, Allen S, Gutierrez P.

J Clin Pharm Ther. 2011 Feb;36(1):64-70. doi: 10.1111/j.1365-2710.2009.01155.x.

PMID:
21198721
15.

Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol.

Berg TM, O'Meara JG, Ou NN, Daniels PR, Moriarty JP, Bergstrahl EJ, Dierkhising RA, Manning DM.

Pharmacotherapy. 2013 Nov;33(11):1165-74. doi: 10.1002/phar.1280. Epub 2013 Apr 26.

PMID:
23625787
17.

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E.

Chest. 2004 Sep;126(3 Suppl):204S-233S. Erratum in: Chest. 2005 Jan;127(1):415-6. Dosage error in article text.

PMID:
15383473
18.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
19.
20.

Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.

Lee R, Wen A, Berube C.

Am J Health Syst Pharm. 2011 May 1;68(9):814-7. doi: 10.2146/ajhp100159.

PMID:
21515865

Supplemental Content

Support Center